Functional analysis of siglecs in pathological progression of multiple scerosis.

Projektinformationen

SIGLECS

ID Finanzhilfevereinbarung: HPMI-CT-2002-00230

Startdatum 1 Dezember 2002

Enddatum 30 November 2006

Finanziert unter

• Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Gesamtkosten € 169 344,00

EU-Beitrag € 169 344,00

Koordiniert durch

CELLTECH R&D LTD
United Kingdom

Ziel

The pathological role of disregulated single expression in the CNS will be investigated for multiple sclerosis.

Wissenschaftliches Gebiet

• medical and health sciences › basic medicine › neurology › multiple sclerosis
• natural sciences › mathematics › pure mathematics › mathematical analysis › functional analysis

Programm/Programme

• FP5-HUMAN POTENTIAL - Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Thema/Themen

Data not available

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

BUR - Bursaries, grants, fellowships

Koordinator

CELLTECH R&D LTD

• EU-Beitrag: Keine Daten
• Adresse: Bath Road 208 ; SL1 3WE SLOUGH ; Vereinigtes Königreich
• Gesamtkosten: Keine Daten